More
    Guided Solutions - Connecting Talent With Innovation/div>

    GS MedTech Funding Tracker – Saluda, WELLSTAR and more

    Strategic capital and acquisitions are driving rapid progress across multiple therapeutic and diagnostic areas. With funding flowing into neuromodulation, AI diagnostics, surgical robotics, and remote monitoring, the industry is turning ambitious ideas into real-world...

    GS MedTech Funding Tracker – Saluda, WELLSTAR and more

    Strategic capital and acquisitions are driving rapid progress across multiple therapeutic and diagnostic areas. With funding flowing into neuromodulation, AI diagnostics, surgical robotics, and...

    Subsense expands financing to $27M for non-surgical brain-computer interfaces

    Subsense, a developer of non-surgical invasive, nanoparticle-based brain-computer interfaces (BCIs), has added $10 million in new capital following positive early breakthroughs, bringing total funding...

    Neurovalens receives FDA approval for weight management device

    Neurovalens, the Belfast-based neuro-technology company, has been granted approval by the US Food & Drug Administration (FDA) for Modius Lean, its prescribed treatment for...

    FDA clears HeartBeam’s at-home arrhythmia assessment tool

    HeartBeam has secured US Food and Drug Administration (FDA) clearance for its 12-lead electrocardiogram (ECG) synthesis software, setting the arrhythmia assessment tool up for...
    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    JenaValve reports positive Trilogy heart valve data for aortic regurgitation

    JenaValve announced new results from an expanded patient cohort supporting the use of its Trilogy transcatheter heart valve (THV) system. Results from the ALIGN-AR pivotal...

    Vexev robotic ultrasound study meets endpoints

    Vexev and U.S. Renal Care announced successful results from the CANSCAN trial of the VxWave robotic ultrasound imaging system. Sydney, Australia-based Vexev develops the...

    Hyperion completes first-in-human study of Ivy robotic vascular access platform

    Hyperion Surgical announced today that it completed the world’s first robotic-assisted intravenous (IV) catheterisation using its Ivy platform. Ivy integrates advanced imaging, AI and robotic...

    AtriCure treats first patient in the BoxX-NoAF clinical trial

    AtriCure, a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced...

    Innovation

    Regulatory Approvals

    GS MedTech Funding Tracker – Saluda, WELLSTAR and more

    Strategic capital and acquisitions are driving rapid progress across multiple therapeutic and diagnostic areas. With funding flowing into neuromodulation, AI diagnostics, surgical robotics, and...

    Subsense expands financing to $27M for non-surgical brain-computer interfaces

    Subsense, a developer of non-surgical invasive, nanoparticle-based brain-computer interfaces (BCIs), has added $10 million in new capital following positive early breakthroughs, bringing total funding...

    Neurovalens receives FDA approval for weight management device

    Neurovalens, the Belfast-based neuro-technology company, has been granted approval by the US Food & Drug Administration (FDA) for Modius Lean, its prescribed treatment for...

    FDA clears HeartBeam’s at-home arrhythmia assessment tool

    HeartBeam has secured US Food and Drug Administration (FDA) clearance for its 12-lead electrocardiogram (ECG) synthesis software, setting the arrhythmia assessment tool up for...

    M&A

    Archives

    Latest articles